Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:academic_journal
|
| gptkbp:abbreviation |
gptkb:CNS_Drugs
|
| gptkbp:country |
gptkb:New_Zealand
|
| gptkbp:discipline |
gptkb:pharmacy
|
| gptkbp:editor |
gptkb:Kate_Palmer
|
| gptkbp:established |
1994
|
| gptkbp:focus |
central nervous system drugs
|
| gptkbp:frequency |
monthly
|
| gptkbp:impact |
2022
6.497 |
| gptkbp:ISSN |
1172-7047
1179-1934 |
| gptkbp:language |
English
|
| gptkbp:openAccess |
gptkb:hybrid
|
| gptkbp:peerReviewed |
yes
|
| gptkbp:publisher |
gptkb:Springer_Nature
gptkb:Adis_International |
| gptkbp:subjectArea |
neurology
psychiatry clinical pharmacology |
| gptkbp:website |
https://www.springer.com/journal/40263
|
| gptkbp:bfsParent |
gptkb:Adis_International
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
CNS Drugs
|